U.S. flag

An official website of the United States government

NM_000396.4(CTSK):c.746T>A (p.Ile249Asn) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 9, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003738095.1

Allele description [Variation Report for NM_000396.4(CTSK):c.746T>A (p.Ile249Asn)]

NM_000396.4(CTSK):c.746T>A (p.Ile249Asn)

Gene:
CTSK:cathepsin K [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q21.3
Genomic location:
Preferred name:
NM_000396.4(CTSK):c.746T>A (p.Ile249Asn)
HGVS:
  • NC_000001.11:g.150799582A>T
  • NG_011848.1:g.13755T>A
  • NM_000396.4:c.746T>AMANE SELECT
  • NP_000387.1:p.Ile249Asn
  • NC_000001.10:g.150772058A>T
Protein change:
I249N
Links:
dbSNP: rs199919553
NCBI 1000 Genomes Browser:
rs199919553
Molecular consequence:
  • NM_000396.4:c.746T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004550689Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Oct 9, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical and genetic characterization of three Russian patients with pycnodysostosis due to pathogenic variants in the CTSK gene.

Markova TV, Kenis V, Melchenko E, Guseva D, Osipova D, Galeeva N, Nagornova T, Dadali EL.

Mol Genet Genomic Med. 2022 May;10(5):e1904. doi: 10.1002/mgg3.1904. Epub 2022 Mar 21.

PubMed [citation]
PMID:
35315254
PMCID:
PMC9034671

Molecular analysis and characterization of nine novel CTSK mutations in twelve patients affected by pycnodysostosis. Mutation in brief #961. Online.

Donnarumma M, Regis S, Tappino B, Rosano C, Assereto S, Corsolini F, Di Rocco M, Filocamo M.

Hum Mutat. 2007 May;28(5):524.

PubMed [citation]
PMID:
17397052
See all PubMed Citations (7)

Details of each submission

From Invitae, SCV004550689.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change replaces isoleucine, which is neutral and non-polar, with asparagine, which is neutral and polar, at codon 249 of the CTSK protein (p.Ile249Asn). This variant is present in population databases (no rsID available, gnomAD 0.007%). This missense change has been observed in individuals with pycnodysostosis (PMID: 35315254). ClinVar contains an entry for this variant (Variation ID: 1301984). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CTSK protein function. This variant disrupts the p.Ile249 amino acid residue in CTSK. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17397052, 24767306, 25725806, 26892377, 30199612). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024